✦ LIBER ✦

The chemical evolution of N,N-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethylamine (L-741,604) and analogues: Potent and selective agonists for 5-HT1D receptors

✍ Scribed by Francine Sternfeld; Raymond Baker; Howard B. Broughton; Alexander R. Guiblin; Richard A. Jelley; Victor G. Matassa; Austin J. Reeve; Margaret S. Beer; Josephine A. Stanton; Richard J. Hargreaves; Sara L. Shepheard; Jeanette Longmore; Zerin Razzaque; Michael I. Graham; Bindi Sohal; Leslie J. Street

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 326 KB
Volume: 6
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(96)00324-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: 4-Hydroxyl-1- [3-(5

ChemInform Abstract: 4-Hydroxyl-1- [3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D Agonists for the Treatment of Migraine.

✍ Sylvie Bourrain; Joseph G. Neduvelil; Margaret S. Beer; Josephine A. Stanton; Gr 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 39 KB 👁 1 views

The synthesis of three isotopomers of 2-

The synthesis of three isotopomers of 2-methyl-2-(4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl]propyl]phenoxy)propionic acid, a potent and selective peroxisome proliferator-activated receptor alpha agonist

✍ Fengjiun Kuo; Dean K. Clodfelter; Nagy A. Farid; William J. Wheeler; Lennon H. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 184 KB

## Abstract Although fenofibrate (**1a**) is commercially available and clinically effective in lowering serum triglycerides, its activity and sub‐type selectivity at the PPARα receptors are only moderate; therefore, there exists a need for more potent and sub‐type selective PPARα agonists. To that

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

ChemInform Abstract: Synthesis of N-(1-E

ChemInform Abstract: Synthesis of N-(1-Ethyl-4-methylhexahydro-1,4-diazepin-6-yl)nicotinamides and Their Affinities for 5-HT3 and Dopamine D2 Receptors.

✍ Y. HIROKAWA; N. YOSHIDA; S. KATO 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 40 KB 👁 2 views

Synthesis and Structure—Activitiy Relati

Synthesis and Structure—Activitiy Relationships of 4-Amino-5-chloro-N- (1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide Derivatives, Novel and Potent Serotonin 5-HT3 and Dopamine D2 Receptors Dual Antagonist.

✍ Yoshimi Hirokawa; Hiroshi Harada; Takashi Yoshikawa; Naoyuki Yoshida; Shiro Kato 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 69 KB 👁 2 views

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views